Pilot evaluation of continuous subcutaneous glucose monitoring in children with multiple organ dysfunction syndrome.

OBJECTIVE: To evaluate continuous subcutaneous glucose monitoring in pediatric critical illness. DESIGN: Prospective evaluation. SETTING: Mixed university pediatric intensive care unit. PATIENTS: Children aged 1 mo to 16 yrs requiring mechanical ventilation with at least two organ system failures. I...

Descripción completa

Detalles Bibliográficos
Publicado en:Pediatric Critical Care Medicine Vol. 11; no. 3; pp. 415 - 420
Autores principales: Branco RG, Chavan A, Tasker RC
Formato: research tables/charts Journal Article
Publicado: Lippincott Williams & Wilkins 2010 May
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105205028&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 105205028
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        15297535
        N1Y
      jtl: Pediatric Critical Care Medicine
      issn: 15297535
      maglogo: N
    pubinfo:
      dt: 2010 May
      vid: 11
      iid: 3
      pid: 433
      pub: Lippincott Williams & Wilkins
      place: Baltimore, Maryland
    artinfo:
      ui:
        105205028
        105205028
        2010659516
        10.1097/PCC.0b013e3181c59144
        NLM19924024
        105205028
      ppf: 415
      ppct: 5
      formats:
      tig:
        atl: Pilot evaluation of continuous subcutaneous glucose monitoring in children with multiple organ dysfunction syndrome.
      aug:
        au:
          Branco RG
          Chavan A
          Tasker RC
        affil: Department of Paediatrics, School of Clinical Medicine, University of Cambridge, Cambridge, UK. brancori@terra.com.br
      sug:
        subj:
          Blood Glucose Monitoring Methods
          Blood Glucose Monitoring Utilization
          Multiple Organ Dysfunction Syndrome
          Academic Medical Centers
          Adolescence
          Blood Glucose Analysis
          Child
          Child, Preschool
          Data Analysis Software
          Female
          Funding Source
          Human
          Infant
          Intensive Care Units, Pediatric
          Logistic Regression
          Male
          Multiple Regression
          Outcomes (Health Care)
          Pearson's Correlation Coefficient
          Pilot Studies
          Prospective Studies
          Repeated Measures
          Validity
          Adolescent: 13-18 years
          Child: 6-12 years
          Child, Preschool: 2-5 years
          Infant: 1-23 months
          Female
          Male
      ab: OBJECTIVE: To evaluate continuous subcutaneous glucose monitoring in pediatric critical illness. DESIGN: Prospective evaluation. SETTING: Mixed university pediatric intensive care unit. PATIENTS: Children aged 1 mo to 16 yrs requiring mechanical ventilation with at least two organ system failures. INTERVENTIONS: None. MEASUREMENTS: Blood samples obtained from an arterial line, measurements using point-of-care glucometer, and laboratory analysis were compared with continuous subcutaneous glucose monitoring. RESULTS: Fourteen patients yielded 11,880 continuous subcutaneous glucose monitoring measurements; 436 glucometer levels and 34 laboratory levels had mean time-paired glucose values of 108 +/- 29 mg/dL and 110 +/- 25 mg/dL, respectively. Mean continuous subcutaneous glucose monitoring glucose was 101 +/- 31 mg/dL for samples paired with glucometer and 95 +/- 40 mg/dL for samples paired with laboratory tests. Continuous subcutaneous glucose monitoring measurements correlated with glucometer (r = 0.44) and laboratory testing (r = 0.48). Mean absolute differences between continuous subcutaneous glucose monitoring measurement and glucometer and laboratory values were 18 +/- 16 mg/dL and 25 +/- 20 mg/dL, respectively. Clarke error grid analysis found 69% of the measurements to be in zone A (clinically accurate), 29% in zone B (benign errors), and 2% in zone D (failure to detect errors). The mean absolute relative difference between the continuous subcutaneous glucose monitoring measurement and glucometer and laboratory measurements were 17% and 23%, respectively. Bland-Altman analysis showed good agreement between continuous subcutaneous glucose monitoring and the other methods of glucose measurement. However, in the lower range (< or =74 mg/dL) 39% of the continuous subcutaneous glucose monitoring readings had a difference >15 mg/dL. On multiple regressions, only glucometer glucose values, continuous subcutaneous glucose monitoring levels, and base deficit were associated with the mean absolute relative difference. CONCLUSION: The performance of continuous subcutaneous glucose monitoring against point-of-care glucometer and laboratory measurements may be considered 'good' using statistical definitions (Bland-Altman and Clarke error grid analysis). However, there are important limitations in children with large base deficit, being actively cooled, and with glucose in the lower range, which may limit its application.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N